Search | Search by Center | Search by Source | Keywords in Title
Chen H, Goldie S, Waxman A, Gould MK. Potential cost-effectiveness of epoprostenol as first-line therapy for pulmonary arterial hypertension. Poster session presented at: American Thoracic Society Annual International Conference; 2005 May 22; San Diego, CA.